SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients

Juan A Pérez-Bermejo; Serah S Kang; Sarah J. Rockwood; Camille R. Simoneau; David A Joy; Gokul N. Ramadoss; Ana C Silva; Will R. Flanigan; Huihui Li; Ken Nakamura; Jeffrey D. Whitman; Melanie Ott; Bruce R Conklin; Todd C McDevitt.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-265561

Documentos relacionados

  1. SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19.
  2. SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients.
  3. Cell-Specific Mechanisms in the Heart of COVID-19 Patients.
  4. Modeling Cardiac SARS-CoV-2 Infection with Human Pluripotent Stem Cells.
  5. Spatially organized cellular communities form the developing human heart.
  6. SARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node Pacemaker Cells.
  7. Functional Effects of Cardiomyocyte Injury in COVID-19.
  8. Decoding HiPSC-CM's Response to SARS-CoV-2: mapping the molecular landscape of cardiac injury.
  9. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes.
  10. SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study.